Literature DB >> 3882696

Electrophoretic characterization of purified bovine, porcine, murine, rat, and human uterine estrogen receptors.

D B Lubahn, K S McCarty, K S McCarty.   

Abstract

The calf uterine estrogen receptor (E2R) in the presence of sodium molybdate has been purified, 7,000-fold by a single passage over an estradiol affinity column. A dominant 70,000-dalton band and two minor bands at 50,000 and 30,000 daltons were observed by electrophoretic analysis. These bands had been eluted using estradiol, sodium sulfocyanate, CHAPS, and HEPES (pH 7.4) with insulin as a carrier protein. The identities of the protein bands were initially confirmed by their failure to bind the affinity column when saturated with estradiol. This single step purification procedure was reproducible and rapid, with yields of 10-20%, providing 25% purity. Diffusion blot analysis, with specific 35S- and 125I-labeled monoclonal antibodies to E2R, confirmed that the 70,000-dalton band represented the estrogen receptor. Specificity was demonstrated by inhibition of binding of purified E2R by both estradiol and diethylstilbestrol but not testosterone, progesterone, corticosterone, aldosterone, or hydrocortisone. The relative binding affinity of the purified receptor was: ethynyl estradiol greater than 17 beta estradiol greater than estriol greater than or equal to estrone greater than or equal to 17 alpha-estradiol greater than mestranol. Pig, human, mouse, and rat uterine estrogen receptors were similarly purified with the affinity column. As with the calf uterine preparations, a dominant 70,000-dalton band with minor bands at 50,000 and 30,000 daltons was identified by diffusion blot analysis in all the species examined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens.

Authors:  L L Zaulyanov; P S Green; J W Simpkins
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.

Authors:  Yaming Qiao; Lu Wang; Li-Qun Cai; Chen Tan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  J Urol       Date:  2011-01       Impact factor: 7.450

Review 3.  Cell-specific mechanisms of estrogen receptor in the pituitary gland.

Authors:  F Demay; S Geffroy; C Tiffoche; M de Monti; M L Thieulant
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

4.  Molecular cloning and characterization of rat estrogen receptor cDNA.

Authors:  S Koike; M Sakai; M Muramatsu
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

5.  17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells.

Authors:  P S Green; J Bishop; J W Simpkins
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

6.  17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.

Authors:  Yaming Qiao; Zhi-Kai Zhang; Li-Qun Cai; Chen Tan; Julianne L Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2007-12-01       Impact factor: 4.104

7.  Nuclear estrogen receptor molecular heterogeneity in the mouse uterus.

Authors:  T S Golding; K S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.